Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal ...

In OPTIMAAL and ELITE II, there were trends toward an excess of deaths in the losartan groups. These trials are important in two respects.

Dec 7, 2002 · Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised ...

The OPTIMAAL trial: losartan or captopril after acute myocardial infarction.

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction - OPTIMAAL. Nov 17, 2002.

Sep 7, 2002 · The OPTIMAAL trial compared the treatment effect of losartan 50 mg once daily with captopril 50 mg three times daily on mortality and morbidity ...

The Optimal Trial in Myocardial Infarction with the Angiotensin II Antagonist Losartan (OPTIMAAL) compares the selective, angiotensin II receptor antagonist ...

Nov 23, 2023 · a multicentre, randomised trial to test the hypothesis that the angiotensin II antagonist losartan would be superior or non-inferior to the ACE ...

optimum , optimal [adjective] the best possible or most suitable. (Translation of optimaal from the PASSWORD Dutch–English Dictionary © 2014 K Dictionaries ...

The Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan (OPTIMAAL) study is a multicenter, double-blind, randomized ...